https://www.selleckchem.com/pr....oducts/gefitinib-bas
Until recently, trans women have been subsumed within the category of men who have **** with men for HIV-related care. Following a 2016 UNAIDS report finding that trans women globally are 49 times more likely to be living with HIV than the general population, health programmes have sought to expand their reach to this key population. Yet, trans women are often treated as passive subjects to be recruited into programming or clinical trials for HIV-related care. This paper uses case studies of two community-based clinics i
Like
Comment
Share
